易明医药
(002826)
| 流通市值：31.85亿 | | | 总市值：34.84亿 |
| 流通股本：1.74亿 | | | 总股本：1.91亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 297,683,078.19 | 265,948,740.21 | 292,524,500.97 | 427,398,137.38 |
| 交易性金融资产 | 280,000,000 | 250,000,000 | 200,000,000 | - |
| 应收票据及应收账款 | 45,589,434.98 | 44,957,157.84 | 38,557,187.08 | 52,374,607.9 |
| 其中：应收票据 | 738,570 | 91,592 | 342,000 | 12,866,464.7 |
| 应收账款 | 44,850,864.98 | 44,865,565.84 | 38,215,187.08 | 39,508,143.2 |
| 预付款项 | 5,635,784.05 | 2,903,743.44 | 24,099,863.43 | 1,886,974.73 |
| 其他应收款合计 | 2,726,644.07 | 2,865,845.18 | 2,776,904.81 | 2,969,762.96 |
| 存货 | 38,722,725.8 | 48,929,388.73 | 33,126,650.41 | 41,050,668.84 |
| 其他流动资产 | 1,920,309.2 | 170,368.66 | 2,311,520.83 | 1,932,985.52 |
| 流动资产合计 | 672,277,976.29 | 615,775,244.06 | 593,396,627.53 | 527,613,137.33 |
| 非流动资产: | | | | |
| 长期应收款 | 11,671,140.3 | 11,534,850.4 | 11,130,165.12 | 11,145,980.74 |
| 其他非流动金融资产 | 3,573,573.88 | 3,600,279.49 | 3,610,136.94 | 3,615,266.83 |
| 固定资产 | 332,127,929.27 | 335,878,084.4 | 339,917,570.96 | 344,627,986.11 |
| 在建工程 | 1,648,793.87 | 730,303.45 | 169,635.75 | - |
| 无形资产 | 19,176,327.91 | 19,362,679.28 | 19,759,021.71 | 20,695,162.7 |
| 商誉 | 16,668,928.89 | 16,668,928.89 | 16,668,928.89 | 16,668,928.89 |
| 递延所得税资产 | 1,628,889.72 | 1,704,924.1 | 1,858,902.45 | 2,004,272.27 |
| 其他非流动资产 | - | - | - | 98,500 |
| 非流动资产合计 | 386,495,583.84 | 389,480,050.01 | 393,114,361.82 | 398,856,097.54 |
| 资产总计 | 1,058,773,560.13 | 1,005,255,294.07 | 986,510,989.35 | 926,469,234.87 |
| 流动负债: | | | | |
| 短期借款 | 26,769,048.65 | 44,907,378.35 | 35,300,443.1 | 22,819,445.17 |
| 应付票据及应付账款 | 139,047,524.67 | 114,056,502.66 | 109,135,397.93 | 103,512,736.32 |
| 应付账款 | 139,047,524.67 | 114,056,502.66 | 109,135,397.93 | 103,512,736.32 |
| 合同负债 | 1,354,519.08 | 561,865.89 | 985,177.42 | 3,152,408.11 |
| 应付职工薪酬 | 17,206,269.9 | 12,757,689.57 | 10,887,120.48 | 13,439,297.29 |
| 应交税费 | 20,381,268.27 | 9,222,932.48 | 9,766,370.26 | 7,321,177.4 |
| 其他应付款合计 | 46,520,558.53 | 47,499,891.53 | 47,199,088.18 | 24,462,526.61 |
| 其他流动负债 | 176,087.48 | 73,042.56 | 128,073.06 | 409,813.06 |
| 流动负债合计 | 251,455,276.58 | 229,079,303.04 | 213,401,670.43 | 175,117,403.96 |
| 非流动负债: | | | | |
| 递延收益 | 5,171,406.09 | 5,372,771.55 | 5,574,137.01 | 5,775,502.47 |
| 非流动负债合计 | 5,171,406.09 | 5,372,771.55 | 5,574,137.01 | 5,775,502.47 |
| 负债合计 | 256,626,682.67 | 234,452,074.59 | 218,975,807.44 | 180,892,906.43 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 190,677,750 | 190,677,750 | 190,677,750 | 190,677,750 |
| 资本公积 | 229,463,954 | 235,764,877.92 | 233,327,967.03 | 232,661,362.96 |
| 减:库存股 | 48,147,160.64 | 48,147,160.64 | 48,325,124.75 | 50,025,670.68 |
| 其他综合收益 | 407,752.59 | 762,043.91 | 903,100.27 | 969,277.05 |
| 专项储备 | 8,098,739.21 | 7,551,356.71 | 6,840,315.85 | 6,110,992.17 |
| 盈余公积 | 21,861,741.5 | 21,861,741.5 | 21,861,741.5 | 21,861,741.5 |
| 未分配利润 | 399,784,100.8 | 355,577,973.54 | 355,542,076.29 | 336,748,224.36 |
| 归属于母公司股东权益合计 | 802,146,877.46 | 764,048,582.94 | 760,827,826.19 | 739,003,677.36 |
| 少数股东权益 | - | 6,754,636.54 | 6,707,355.72 | 6,572,651.08 |
| 股东权益合计 | 802,146,877.46 | 770,803,219.48 | 767,535,181.91 | 745,576,328.44 |
| 负债和股东权益合计 | 1,058,773,560.13 | 1,005,255,294.07 | 986,510,989.35 | 926,469,234.87 |
| 公告日期 | 2025-10-29 | 2025-08-15 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |